Musk’s Neuralink says second trial implant went well, no thread retraction issue 

(Reuters) – Elon Musk’s brain technology startup Neuralink said its implant, designed to allow paralyzed patients to use digital devices by thinking alone, is working well in a second trial patient.  The company said the patient, identified as Alex, did not face issues of “thread retraction”, unlike Noland Arbaugh, Neuralink’s first patient who received the…

Read More

Amazon must face D.C.’s antitrust lawsuit, appeals court rules

By Jody Godoy (Reuters) – An appeals court in Washington, D.C. revived the district’s lawsuit against Amazon.com Inc on Thursday, saying it plausibly claimed the online retailer’s pricing policies illegally stifle competition. The District of Columbia Court of Appeals reversed a ruling that had dismissed the lawsuit, which accuses Amazon of harming competition through restrictions…

Read More

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS (Reuters) – Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year’s annual ‘Choose France’ business summit. Pfizer said it would invest 500 million euros ($538.5 million) in France to build up its research and development work…

Read More